Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.22 billion.
Market Cap
1.12T
Revenue
105.22B
Profits
-42.66B
PE Ratio
n/a
Profit Margin
-40.55%
Dividend Yield
0.04%
606 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.56B | -0.41% | 911,370 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.70B | -0.61% | 795,945 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 60.52B | -1.55% | 627,337 | 3.21B |
| 4 | ARGX | argenx SE | 54.89B | -1.62% | 228,610 | 3.68B |
| 5 | INSM | Insmed Incorporated | 43.51B | -0.51% | 2,156,039 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.73B | -2.56% | 603,795 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.14B | 0.26% | 1,270,171 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.93B | 1.48% | 10,225,308 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.13B | 2.05% | 2,276,020 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.50B | -0.87% | 781,395 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.40B | 1.48% | 1,712,658 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.58B | -0.99% | 5,102,684 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.19B | -1.50% | 1,936,108 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 14.12B | -2.66% | 2,435,539 | - |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.23B | -0.16% | 1,714,985 | 966.96M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.11B | -1.52% | 220,886 | 740.64M |
| 17 | ASND | Ascendis Pharma A/S | 12.55B | -1.51% | 470,721 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.94B | -0.02% | 2,193,588 | 2.29B |
| 19 | MRNA | Moderna, Inc. | 10.82B | 8.67% | 16,531,461 | 2.23B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.79B | 0.13% | 2,168,664 | 20.87M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.31B | 1.67% | 909,020 | 4.16B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.26B | -0.78% | 2,159,748 | 3.09B |
| 23 | TECH | Bio-Techne Corporation | 9.61B | -2.93% | 1,707,113 | 1.22B |
| 24 | CORT | Corcept Therapeutics Incorporated | 9.06B | 1.71% | 644,150 | 741.17M |
| 25 | NUVL | Nuvalent, Inc. | 8.51B | 2.56% | 493,382 | - |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.34B | -4.98% | 3,435,354 | 829.45M |
| 27 | ABVX | ABIVAX Société Anonyme | 8.29B | 3.50% | 1,297,120 | 7.07M |
| 28 | CAI | Caris Life Sciences, Inc. | 8.14B | 1.91% | 2,913,561 | 649.06M |
| 29 | CYTK | Cytokinetics, Incorporated | 8.03B | -1.31% | 1,394,870 | 87.21M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.52B | 0.80% | 492,282 | 561.26M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.45B | 0.60% | 1,534,328 | 1.24B |
| 32 | MRUS | Merus N.V. | 7.29B | -0.08% | 701,439 | 56.61M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.98B | -1.04% | 539,878 | 174.33M |
| 34 | CDTX | Cidara Therapeutics, Inc. | 6.93B | -0.06% | 637,053 | 302.00K |
| 35 | KRYS | Krystal Biotech, Inc. | 6.79B | 5.48% | 492,363 | 373.16M |
| 36 | PTCT | PTC Therapeutics, Inc. | 6.20B | -0.76% | 837,355 | 1.78B |
| 37 | PRAX | Praxis Precision Medicines, Inc. | 6.20B | 30.54% | 2,893,872 | 7.46M |
| 38 | PCVX | Vaxcyte, Inc. | 6.08B | 0.89% | 1,051,820 | - |
| 39 | COGT | Cogent Biosciences, Inc. | 5.90B | -1.37% | 1,840,481 | - |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.60B | 2.66% | 1,473,125 | 209.22M |
| 41 | CRSP | CRISPR Therapeutics AG | 5.42B | -2.23% | 1,660,247 | 38.34M |
| 42 | BLTE | Belite Bio, Inc | 5.23B | -0.84% | 314,480 | - |
| 43 | LEGN | Legend Biotech Corporation | 5.20B | 1.15% | 1,710,866 | 909.05M |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.18B | 1.66% | 733,690 | - |
| 45 | CELC | Celcuity Inc. | 4.89B | -0.23% | 872,506 | - |
| 46 | KYMR | Kymera Therapeutics, Inc. | 4.79B | 0.59% | 392,343 | 43.74M |
| 47 | ADMA | ADMA Biologics, Inc. | 4.72B | -1.29% | 3,032,163 | 488.56M |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.64B | 3.35% | 2,122,294 | 1.05B |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.59B | -0.40% | 1,119,277 | - |
| 50 | TGTX | TG Therapeutics, Inc. | 4.50B | -1.98% | 1,132,809 | 531.90M |
| 51 | AKRO | Akero Therapeutics, Inc. | 4.49B | -0.15% | 4,670,631 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.43B | -1.58% | 566,608 | 1.54M |
| 53 | CNTA | Centessa Pharmaceuticals plc | 4.37B | 1.18% | 887,811 | 15.00M |
| 54 | VKTX | Viking Therapeutics, Inc. | 4.36B | -0.05% | 2,745,898 | - |
| 55 | ACLX | Arcellx, Inc. | 4.02B | 1.62% | 1,432,071 | 35.90M |
| 56 | IMVT | Immunovant, Inc. | 4.00B | -0.31% | 829,561 | - |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 4.00B | -1.65% | 1,208,882 | 35.24M |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.82B | 0.13% | 1,284,534 | 317.93M |
| 59 | IRON | Disc Medicine, Inc. | 3.52B | -0.53% | 233,746 | - |
| 60 | MIRM | Mirum Pharmaceuticals, Inc. | 3.52B | -4.26% | 403,997 | 471.79M |
| 61 | RARE | Ultragenyx Pharmaceutical Inc. | 3.50B | -0.44% | 1,281,227 | 630.60M |
| 62 | CGON | CG Oncology, Inc. | 3.49B | -3.20% | 744,809 | 2.17M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.48B | 0.90% | 518,478 | 7.50M |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.47B | -0.07% | 249,597 | 366.10M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.33B | 0.72% | 61,367 | 664.23M |
| 66 | RCUS | Arcus Biosciences, Inc. | 3.15B | 0.75% | 1,275,296 | 240.00M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.14B | -0.39% | 712,349 | 214.83M |
| 68 | TVTX | Travere Therapeutics, Inc. | 3.13B | -0.93% | 1,573,640 | 435.83M |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.06B | -1.36% | 651,884 | 70.79M |
| 70 | FOLD | Amicus Therapeutics, Inc. | 3.05B | -0.50% | 3,515,956 | 598.70M |
| 71 | MLYS | Mineralys Therapeutics, Inc. | 3.05B | -1.05% | 979,916 | - |
| 72 | AAPG | Ascentage Pharma Group International | 3.00B | 7.10% | 1,472 | 54.52M |
| 73 | LQDA | Liquidia Corporation | 2.99B | 1.44% | 1,023,287 | 69.22M |
| 74 | APLS | Apellis Pharmaceuticals, Inc. | 2.99B | 6.49% | 4,341,146 | 1.02B |
| 75 | NUVB | Nuvation Bio Inc. | 2.93B | 2.89% | 6,070,699 | 26.75M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.93B | -0.75% | 2,021,996 | - |
| 77 | DYN | Dyne Therapeutics, Inc. | 2.90B | -1.79% | 2,574,508 | - |
| 78 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.89B | 1.95% | 1,081,535 | 578.20M |
| 79 | VERA | Vera Therapeutics, Inc. | 2.87B | 5.37% | 2,548,533 | - |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.76B | -2.49% | 1,161,305 | 98.68M |
| 81 | OCUL | Ocular Therapeutix, Inc. | 2.68B | 1.21% | 2,684,388 | 55.78M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.67B | -6.30% | 2,140,740 | 55.70M |
| 83 | TERN | Terns Pharmaceuticals, Inc. | 2.64B | 8.22% | 6,287,510 | - |
| 84 | SYRE | Spyre Therapeutics, Inc. | 2.60B | -0.18% | 548,023 | - |
| 85 | EWTX | Edgewise Therapeutics, Inc. | 2.50B | -0.51% | 756,029 | - |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.46B | -4.27% | 17,124,360 | 43.69M |
| 87 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | -2.45% | 2,658,976 | 2.41B |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | 4.13% | 726,068 | 825.94M |
| 89 | MESO | Mesoblast Limited | 2.26B | 3.96% | 247,877 | 17.20M |
| 90 | IBRX | ImmunityBio, Inc. | 2.26B | -0.43% | 6,843,903 | 82.56M |
| 91 | ADPT | Adaptive Biotechnologies Corporation | 2.25B | -15.52% | 7,131,157 | 252.75M |
| 92 | ZLAB | Zai Lab Limited | 2.17B | -2.26% | 1,019,397 | 441.63M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.14B | -1.56% | 2,164,168 | - |
| 94 | ZBIO | Zenas BioPharma, Inc. | 2.11B | 3.33% | 303,483 | 15.00M |
| 95 | GPCR | Structure Therapeutics Inc. | 2.10B | 5.21% | 1,170,210 | - |
| 96 | GLPG | Galapagos NV | 2.07B | -0.57% | 40,423 | 336.64M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 2.02% | 1,495,858 | 265.81M |
| 98 | MAZE | Maze Therapeutics, Inc. | 2.01B | -2.09% | 245,067 | 2.50M |
| 99 | ZYME | Zymeworks Inc. | 2.00B | 0.64% | 562,155 | 134.48M |
| 100 | IMCR | Immunocore Holdings plc | 1.96B | -3.58% | 239,440 | 379.59M |
| 101 | CLDX | Celldex Therapeutics, Inc. | 1.96B | -0.51% | 1,057,884 | 2.60M |
| 102 | DNTH | Dianthus Therapeutics, Inc. | 1.90B | -1.01% | 425,497 | 3.08M |
| 103 | NRIX | Nurix Therapeutics, Inc. | 1.83B | 0.39% | 1,228,461 | 83.69M |
| 104 | VCEL | Vericel Corporation | 1.83B | -1.52% | 351,154 | 258.72M |
| 105 | IMNM | Immunome, Inc. | 1.81B | -1.64% | 782,437 | 9.68M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.80B | -1.44% | 209,121 | - |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 2.94% | 2,355,995 | 111.30M |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.76B | -0.58% | 602,705 | 205.63M |
| 109 | MNKD | MannKind Corporation | 1.74B | -0.53% | 1,781,294 | 313.79M |
| 110 | TRVI | Trevi Therapeutics, Inc. | 1.73B | - | 2,645,421 | - |
| 111 | PHVS | Pharvaris N.V. | 1.72B | -4.59% | 454,911 | - |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | 1.13% | 850,238 | 44.79M |
| 113 | ATAI | Atai Beckley N.V. | 1.57B | -1.82% | 2,843,583 | 3.02M |
| 114 | SVRA | Savara Inc. | 1.57B | 2.04% | 4,013,887 | - |
| 115 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.56B | -2.00% | 1,105,639 | -665.00K |
| 116 | INVA | Innoviva, Inc. | 1.55B | -0.29% | 508,252 | 388.52M |
| 117 | UPB | Upstream Bio, Inc. | 1.50B | 0.04% | 399,840 | 2.80M |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.49B | -0.29% | 355,161 | - |
| 119 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.47B | 6.10% | 1,451,519 | 42.34M |
| 120 | ARDX | Ardelyx, Inc. | 1.45B | 1.01% | 4,052,099 | 398.23M |
| 121 | MBX | MBX Biosciences, Inc. | 1.44B | 4.68% | 823,820 | - |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.41B | 2.79% | 403,790 | - |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | -0.20% | 3,004,091 | 6.31M |
| 124 | SANA | Sana Biotechnology, Inc. | 1.37B | -0.97% | 5,888,820 | - |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.33B | -4.00% | 896,629 | 8.36M |
| 126 | QURE | uniQure N.V. | 1.33B | -6.20% | 3,495,444 | 15.75M |
| 127 | FTRE | Fortrea Holdings Inc. | 1.32B | -1.79% | 1,744,656 | 2.76B |
| 128 | INBX | Inhibrx Biosciences, Inc. | 1.30B | 2.36% | 140,250 | 1.40M |
| 129 | TNGX | Tango Therapeutics, Inc. | 1.30B | -2.73% | 1,680,841 | 66.50M |
| 130 | ELVN | Enliven Therapeutics, Inc. | 1.29B | 1.92% | 523,219 | - |
| 131 | KOD | Kodiak Sciences Inc. | 1.29B | -1.70% | 582,796 | - |
| 132 | PGEN | Precigen, Inc. | 1.27B | -4.00% | 3,104,769 | 6.31M |
| 133 | BHVN | Biohaven Ltd. | 1.27B | -0.62% | 3,886,431 | - |
| 134 | OCS | Oculis Holding AG | 1.25B | 10.05% | 213,590 | 992.00K |
| 135 | WVE | Wave Life Sciences Ltd. | 1.25B | -1.71% | 2,542,918 | 109.23M |
| 136 | IMTX | Immatics N.V. | 1.24B | -14.24% | 1,648,064 | 99.45M |
| 137 | XNCR | Xencor, Inc. | 1.24B | -4.63% | 552,553 | 150.13M |
| 138 | ANAB | AnaptysBio, Inc. | 1.23B | 2.56% | 357,700 | 169.47M |
| 139 | CAPR | Capricor Therapeutics, Inc. | 1.23B | 5.87% | 7,040,717 | 11.13M |
| 140 | MNMD | Mind Medicine (MindMed) Inc. | 1.22B | -0.64% | 1,404,816 | - |
| 141 | SEPN | Septerna, Inc. | 1.20B | 2.29% | 346,900 | 22.05M |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.19B | 7.13% | 251,061 | - |
| 143 | ALMS | Alumis Inc. | 1.16B | 33.98% | 4,350,229 | 22.12M |
| 144 | NKTR | Nektar Therapeutics | 1.16B | -1.37% | 342,873 | 62.60M |
| 145 | CVAC | CureVac N.V. | 1.15B | - | 405,222 | 83.00M |
| 146 | TYRA | Tyra Biosciences, Inc. | 1.15B | -2.76% | 629,355 | - |
| 147 | GLUE | Monte Rosa Therapeutics, Inc. | 1.13B | 0.87% | 719,558 | 181.54M |
| 148 | PHAR | Pharming Group N.V. | 1.12B | -3.46% | 28,945 | 362.27M |
| 149 | NVAX | Novavax, Inc. | 1.12B | 0.73% | 3,719,860 | 1.06B |
| 150 | NTLA | Intellia Therapeutics, Inc. | 1.11B | -1.33% | 4,027,526 | 57.53M |
| 151 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.10B | 18.63% | 549,269 | - |
| 152 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -3.12% | 2,036,622 | 266.14M |
| 153 | URGN | UroGen Pharma Ltd. | 1.08B | -5.35% | 845,576 | 96.52M |
| 154 | ORIC | ORIC Pharmaceuticals, Inc. | 1.07B | -3.42% | 1,394,517 | - |
| 155 | ABCL | AbCellera Biologics Inc. | 1.07B | -2.47% | 2,293,565 | 35.33M |
| 156 | MLTX | MoonLake Immunotherapeutics | 1.06B | -0.63% | 1,255,409 | - |
| 157 | KURA | Kura Oncology, Inc. | 1.04B | -0.25% | 1,310,446 | 104.03M |
| 158 | MDXG | MiMedx Group, Inc. | 1.03B | 1.02% | 524,397 | 393.44M |
| 159 | NBTX | Nanobiotix S.A. | 1.03B | -3.07% | 39,774 | 11.93M |
| 160 | AVBP | ArriVent BioPharma, Inc. | 1.02B | 1.40% | 643,086 | - |
| 161 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | -0.82% | 710,939 | 147.19M |
| 162 | BCAX | Bicara Therapeutics Inc. | 997.03M | -2.99% | 702,052 | - |
| 163 | JANX | Janux Therapeutics, Inc. | 993.04M | 0.67% | 2,141,716 | 10.00M |
| 164 | CMPX | Compass Therapeutics, Inc. | 983.58M | -0.18% | 1,136,264 | 850.00K |
| 165 | SPRY | ARS Pharmaceuticals, Inc. | 981.57M | -0.40% | 1,316,328 | 142.77M |
| 166 | YDES | YD Bio Limited | 977.80M | 8.89% | 91,502 | 510.36K |
| 167 | RZLT | Rezolute, Inc. | 966.22M | 7.42% | 2,418,720 | - |
| 168 | RAPT | RAPT Therapeutics, Inc. | 955.06M | -0.01% | 363,674 | - |
| 169 | MRVI | Maravai LifeSciences Holdings, Inc. | 946.12M | - | 920,221 | 192.44M |
| 170 | TBPH | Theravance Biopharma, Inc. | 939.97M | -0.80% | 245,017 | 80.33M |
| 171 | ERAS | Erasca, Inc. | 927.74M | 2.51% | 1,658,096 | - |
| 172 | GHRS | GH Research PLC | 923.62M | -3.00% | 190,867 | - |
| 173 | VIR | Vir Biotechnology, Inc. | 904.31M | -4.13% | 1,870,763 | 16.86M |
| 174 | RIGL | Rigel Pharmaceuticals, Inc. | 887.96M | 3.25% | 447,248 | 282.08M |
| 175 | IOVA | Iovance Biotherapeutics, Inc. | 873.33M | - | 6,621,340 | 250.43M |
| 176 | ABUS | Arbutus Biopharma Corporation | 850.07M | 0.23% | 730,347 | 14.61M |
| 177 | GERN | Geron Corporation | 836.25M | 3.15% | 4,670,816 | 183.40M |
| 178 | LENZ | LENZ Therapeutics, Inc. | 836.07M | -4.23% | 396,590 | 17.50M |
| 179 | REPL | Replimune Group, Inc. | 832.28M | 0.76% | 1,098,781 | - |
| 180 | CRMD | CorMedix Inc. | 832.01M | -0.75% | 1,609,622 | 214.30M |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 830.48M | 0.18% | 1,886,165 | 1.43M |
| 182 | ARVN | Arvinas, Inc. | 821.43M | 1.91% | 950,845 | 312.30M |
| 183 | DAWN | Day One Biopharmaceuticals, Inc. | 813.19M | -5.04% | 1,503,257 | 133.67M |
| 184 | MPLT | MapLight Therapeutics, Inc. | 806.93M | 0.82% | 361,530 | - |
| 185 | VSTM | Verastem, Inc. | 799.60M | -2.26% | 851,634 | 13.38M |
| 186 | GOSS | Gossamer Bio, Inc. | 770.75M | 0.30% | 2,221,448 | 44.05M |
| 187 | OMER | Omeros Corporation | 769.27M | -1.63% | 1,034,969 | - |
| 188 | IVA | Inventiva S.A. | 766.71M | -1.20% | 147,979 | 19.93M |
| 189 | VALN | Valneva SE | 763.16M | 1.81% | 8,134 | 211.09M |
| 190 | ATXS | Astria Therapeutics, Inc. | 738.11M | -1.45% | 529,656 | 706.00K |
| 191 | GYRE | Gyre Therapeutics, Inc. | 725.31M | 1.01% | 76,962 | 107.27M |
| 192 | PROK | ProKidney Corp. | 703.95M | -8.95% | 1,571,669 | 744.00K |
| 193 | MGTX | MeiraGTx Holdings plc | 696.25M | 0.58% | 510,713 | 27.42M |
| 194 | ANNX | Annexon, Inc. | 687.15M | 2.67% | 1,941,050 | - |
| 195 | LXEO | Lexeo Therapeutics, Inc. | 682.43M | 2.86% | 913,865 | - |
| 196 | CTMX | CytomX Therapeutics, Inc. | 669.27M | -3.19% | 929,308 | 113.63M |
| 197 | RGNX | REGENXBIO Inc. | 666.20M | 1.39% | 555,105 | 161.32M |
| 198 | PRME | Prime Medicine, Inc. | 662.12M | -2.86% | 2,669,570 | 5.98M |
| 199 | EVMN | Evommune, Inc. | 658.70M | -0.14% | 71,856 | 3.00M |
| 200 | CRVS | Corvus Pharmaceuticals, Inc. | 657.95M | - | 1,275,670 | - |
| 201 | CGEM | Cullinan Therapeutics, Inc. | 625.62M | 0.09% | 779,637 | - |
| 202 | VTYX | Ventyx Biosciences, Inc. | 622.25M | 9.00% | 3,239,991 | - |
| 203 | JBIO | Jade Biosciences, Inc. | 621.06M | 8.87% | 534,857 | - |
| 204 | FDMT | 4D Molecular Therapeutics, Inc. | 611.35M | -4.38% | 485,629 | 120.00K |
| 205 | DRUG | Bright Minds Biosciences Inc. | 598.07M | 11.03% | 196,510 | - |
| 206 | PRTA | Prothena Corporation plc | 595.90M | -0.81% | 434,643 | 11.79M |
| 207 | DSGN | Design Therapeutics, Inc. | 556.54M | -0.51% | 296,527 | - |
| 208 | ASMB | Assembly Biosciences, Inc. | 553.76M | -0.74% | 28,726 | 37.19M |
| 209 | ALT | Altimmune, Inc. | 546.75M | -1.32% | 2,578,414 | 20.00K |
| 210 | ENGN | enGene Holdings Inc. | 539.66M | -1.82% | 188,799 | - |
| 211 | ABSI | Absci Corporation | 538.33M | -4.02% | 4,249,747 | 2.82M |
| 212 | MNPR | Monopar Therapeutics Inc. | 537.15M | 1.15% | 104,170 | - |
| 213 | LYEL | Lyell Immunopharma, Inc. | 535.76M | 0.04% | 33,585 | 41.00K |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 525.74M | 0.43% | 1,420,103 | 180.61M |
| 215 | IVVD | Invivyd, Inc. | 519.86M | 0.45% | 3,560,861 | 50.04M |
| 216 | NAGE | Niagen Bioscience, Inc. | 516.57M | -3.73% | 616,440 | 124.71M |
| 217 | LXRX | Lexicon Pharmaceuticals, Inc. | 508.76M | -1.41% | 1,553,708 | 70.86M |
| 218 | LBRX | LB Pharmaceuticals Inc | 493.33M | 1.30% | 227,404 | - |
| 219 | BCYC | Bicycle Therapeutics plc | 490.43M | -0.98% | 241,101 | 28.34M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 490.35M | 0.58% | 663,740 | 84.39M |
| 221 | NBP | NovaBridge Biosciences | 481.81M | 4.76% | 450,445 | - |
| 222 | FULC | Fulcrum Therapeutics, Inc. | 481.65M | 1.60% | 1,682,338 | 80.00M |
| 223 | DBVT | DBV Technologies S.A. | 474.46M | 6.51% | 1,443,939 | 5.50M |
| 224 | BNTC | Benitec Biopharma Inc. | 459.85M | 3.03% | 306,750 | - |
| 225 | DMAC | DiaMedica Therapeutics Inc. | 457.24M | 1.74% | 240,752 | - |
| 226 | SLDB | Solid Biosciences Inc. | 449.54M | -2.53% | 1,106,578 | - |
| 227 | KROS | Keros Therapeutics, Inc. | 423.30M | 7.01% | 1,114,626 | 246.72M |
| 228 | ENTA | Enanta Pharmaceuticals, Inc. | 421.39M | 3.62% | 334,049 | 65.32M |
| 229 | ANRO | Alto Neuroscience, Inc. | 417.22M | 0.37% | 206,643 | - |
| 230 | LCTX | Lineage Cell Therapeutics, Inc. | 416.80M | -1.15% | 852,822 | 10.82M |
| 231 | IMRX | Immuneering Corporation | 413.25M | -4.33% | 742,428 | - |
| 232 | AUTL | Autolus Therapeutics plc | 412.52M | -1.27% | 1,591,609 | 51.13M |
| 233 | AURA | Aura Biosciences, Inc. | 408.33M | -0.31% | 90,656 | - |
| 234 | ADCT | ADC Therapeutics SA | 407.56M | -7.06% | 1,844,282 | 75.21M |
| 235 | AVXL | Anavex Life Sciences Corp. | 393.13M | -1.12% | 1,077,696 | - |
| 236 | PRTC | PureTech Health plc | 392.85M | 7.50% | 5,172 | 6.39M |
| 237 | TENX | Tenax Therapeutics, Inc. | 391.50M | 3.21% | 169,523 | - |
| 238 | OCGN | Ocugen, Inc. | 381.03M | -1.61% | 2,360,349 | 5.37M |
| 239 | PEPG | PepGen Inc. | 373.99M | 2.45% | 457,603 | - |
| 240 | TECX | Tectonic Therapeutic, Inc. | 372.83M | -5.05% | 251,393 | - |
| 241 | NMRA | Neumora Therapeutics, Inc. | 370.94M | -2.42% | 472,285 | - |
| 242 | TRDA | Entrada Therapeutics, Inc. | 370.81M | 1.77% | 102,397 | 61.52M |
| 243 | XOMA | XOMA Royalty Corporation | 370.38M | -3.92% | 44,533 | 47.11M |
| 244 | GALT | Galectin Therapeutics Inc. | 370.07M | -8.89% | 774,100 | - |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 359.30M | -2.92% | 1,094,034 | - |
| 246 | FBRX | Forte Biosciences, Inc. | 355.38M | -3.06% | 72,994 | - |
| 247 | XFOR | X4 Pharmaceuticals, Inc. | 348.00M | 4.74% | 883,688 | 33.98M |
| 248 | CLLS | Cellectis S.A. | 346.65M | -1.86% | 63,178 | 82.55M |
| 249 | KYTX | Kyverna Therapeutics, Inc. | 341.61M | -0.51% | 267,808 | - |
| 250 | VTVT | vTv Therapeutics Inc. | 339.38M | -0.07% | 8,119 | 17.00K |
| 251 | DRTS | Alpha Tau Medical Ltd. | 331.68M | -4.19% | 80,484 | - |
| 252 | SLN | Silence Therapeutics plc | 328.75M | -2.38% | 248,196 | 25.83M |
| 253 | MREO | Mereo BioPharma Group plc | 327.81M | 0.98% | 1,635,075 | 500.00K |
| 254 | CTNM | Contineum Therapeutics, Inc. | 322.17M | 0.55% | 54,028 | - |
| 255 | ALLO | Allogene Therapeutics, Inc. | 321.36M | -0.69% | 2,434,479 | 22.00K |
| 256 | VNDA | Vanda Pharmaceuticals Inc. | 318.53M | 3.65% | 1,808,217 | 212.07M |
| 257 | AVTX | Avalo Therapeutics, Inc. | 318.43M | -2.17% | 134,177 | 192.00K |
| 258 | LRMR | Larimar Therapeutics, Inc. | 316.68M | 0.54% | 623,670 | - |
| 259 | ACRS | Aclaris Therapeutics, Inc. | 316.37M | -2.99% | 834,316 | 15.74M |
| 260 | NGNE | Neurogene Inc. | 314.13M | -4.16% | 161,279 | 925.00K |
| 261 | RLMD | Relmada Therapeutics, Inc. | 310.93M | 6.00% | 637,195 | - |
| 262 | CYBN | Cybin Inc. | 298.92M | 0.67% | 412,856 | - |
| 263 | AARD | Aardvark Therapeutics, Inc. | 295.25M | 9.35% | 228,870 | - |
| 264 | EPRX | Eupraxia Pharmaceuticals Inc. | 292.74M | 6.98% | 179,107 | - |
| 265 | CADL | Candel Therapeutics, Inc. | 292.61M | 1.33% | 983,471 | - |
| 266 | ALDX | Aldeyra Therapeutics, Inc. | 282.77M | -3.69% | 822,360 | - |
| 267 | OABI | OmniAb, Inc. | 280.71M | -1.02% | 455,024 | 21.09M |
| 268 | GUTS | Fractyl Health, Inc. | 279.57M | 3.03% | 4,504,976 | 3.00K |
| 269 | ACIU | AC Immune SA | 277.04M | -2.78% | 158,358 | 5.48M |
| 270 | MIST | Milestone Pharmaceuticals Inc. | 272.24M | 1.52% | 3,459,649 | - |
| 271 | PALI | Palisade Bio, Inc. | 268.21M | - | 2,191,338 | - |
| 272 | PBYI | Puma Biotechnology, Inc. | 267.07M | 0.19% | 243,617 | 212.00M |
| 273 | ABEO | Abeona Therapeutics Inc. | 264.18M | 0.10% | 644,728 | 400.00K |
| 274 | PYXS | Pyxis Oncology, Inc. | 262.75M | -2.31% | 418,025 | 2.82M |
| 275 | CCCC | C4 Therapeutics, Inc. | 258.76M | 3.09% | 2,034,909 | 30.11M |
| 276 | FENC | Fennec Pharmaceuticals Inc. | 257.86M | -2.96% | 71,118 | 38.79M |
| 277 | NAUT | Nautilus Biotechnology, Inc. | 256.40M | -1.93% | 254,902 | - |
| 278 | CBIO | Crescent Biopharma, Inc. | 255.51M | 0.62% | 246,702 | - |
| 279 | IMMP | Immutep Limited | 253.80M | 1.12% | 59,577 | 3.31M |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 248.44M | -5.98% | 242,762 | 2.82M |
| 281 | SLS | SELLAS Life Sciences Group, Inc. | 247.85M | - | 4,274,259 | - |
| 282 | AVIR | Atea Pharmaceuticals, Inc. | 247.66M | 2.59% | 267,924 | - |
| 283 | FHTX | Foghorn Therapeutics Inc. | 246.56M | -4.80% | 129,581 | 24.52M |
| 284 | ACHV | Achieve Life Sciences, Inc. | 245.94M | -3.35% | 472,530 | - |
| 285 | CABA | Cabaletta Bio, Inc. | 245.48M | -0.39% | 2,229,890 | - |
| 286 | ZURA | Zura Bio Limited | 243.19M | -3.86% | 225,205 | - |
| 287 | HRTX | Heron Therapeutics, Inc. | 240.20M | - | 1,700,484 | 155.10M |
| 288 | VYGR | Voyager Therapeutics, Inc. | 237.97M | -1.61% | 408,993 | 31.32M |
| 289 | EDIT | Editas Medicine, Inc. | 236.24M | -0.41% | 1,353,552 | 46.38M |
| 290 | TNYA | Tenaya Therapeutics, Inc. | 234.77M | 2.17% | 1,532,362 | - |
| 291 | TNXP | Tonix Pharmaceuticals Holding Corp. | 231.29M | 0.56% | 592,664 | 10.30M |
| 292 | HUMA | Humacyte, Inc. | 230.34M | -5.38% | 3,958,031 | 1.57M |
| 293 | MDWD | MediWound Ltd. | 226.68M | -1.67% | 33,445 | 20.93M |
| 294 | ETHZ | ETHZilla Corporation | 224.90M | -10.86% | 960,329 | 4.11M |
| 295 | QNCX | Quince Therapeutics, Inc. | 223.28M | 11.39% | 1,801,460 | - |
| 296 | PRQR | ProQR Therapeutics N.V. | 220.17M | -1.42% | 687,089 | 18.86M |
| 297 | TARA | Protara Therapeutics, Inc. | 215.32M | -18.78% | 6,465,027 | - |
| 298 | SGMT | Sagimet Biosciences Inc. | 207.81M | 0.63% | 633,265 | - |
| 299 | TLSA | Tiziana Life Sciences Ltd | 206.75M | -1.69% | 158,053 | - |
| 300 | ARMP | Armata Pharmaceuticals, Inc. | 204.54M | -5.22% | 32,720 | 5.05M |
| 301 | ARCT | Arcturus Therapeutics Holdings Inc. | 202.58M | 4.39% | 1,362,482 | 97.60M |
| 302 | STTK | Shattuck Labs, Inc. | 196.17M | 4.38% | 498,804 | 1.00M |
| 303 | RANI | Rani Therapeutics Holdings, Inc. | 193.20M | 1.27% | 2,332,830 | 1.20M |
| 304 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 189.73M | -4.21% | 261,204 | - |
| 305 | SABS | SAB Biotherapeutics, Inc. | 189.48M | 4.74% | 505,799 | 114.70K |
| 306 | IMMX | Immix Biopharma, Inc. | 186.69M | 14.88% | 1,113,011 | - |
| 307 | IPHA | Innate Pharma S.A. | 179.27M | -1.05% | 12,664 | 14.84M |
| 308 | NTHI | NeOnc Technologies Holdings, Inc. | 179.16M | -1.60% | 75,319 | 59.99K |
| 309 | RNAC | Cartesian Therapeutics, Inc. | 178.90M | -0.29% | 126,134 | 1.09M |
| 310 | CRBU | Caribou Biosciences, Inc. | 177.59M | -2.06% | 726,780 | 9.30M |
| 311 | SRZN | Surrozen, Inc. | 175.37M | 12.23% | 186,826 | 3.60M |
| 312 | GNLX | Genelux Corporation | 174.55M | -0.22% | 135,546 | 8.00K |
| 313 | NVCT | Nuvectis Pharma, Inc. | 171.88M | -0.52% | 104,246 | - |
| 314 | VTGN | Vistagen Therapeutics, Inc. | 171.02M | 1.17% | 1,006,228 | 721.00K |
| 315 | ACTU | Actuate Therapeutics, Inc. | 170.84M | - | 57,145 | - |
| 316 | VOR | Vor Biopharma Inc. | 166.96M | -1.80% | 246,114 | - |
| 317 | SGMO | Sangamo Therapeutics, Inc. | 166.87M | -6.45% | 5,023,635 | 32.88M |
| 318 | CDXS | Codexis, Inc. | 165.29M | 3.39% | 819,531 | 52.93M |
| 319 | ANIX | Anixa Biosciences, Inc. | 157.67M | 1.05% | 183,387 | - |
| 320 | MOLN | Molecular Partners AG | 157.44M | 0.11% | 1,271 | 856.30K |
| 321 | IRD | Opus Genetics, Inc. | 156.55M | 1.79% | 224,319 | 14.63M |
| 322 | SAVA | Cassava Sciences, Inc. | 154.10M | -3.92% | 866,075 | - |
| 323 | CGTX | Cognition Therapeutics, Inc. | 152.71M | -1.70% | 551,682 | - |
| 324 | NBY | NovaBay Pharmaceuticals, Inc. | 152.47M | 11.01% | 352,420 | 10.30M |
| 325 | CAMP | Camp4 Therapeutics Corporation | 152.36M | -4.13% | 67,415 | 3.80M |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 152.12M | -1.48% | 2,107,313 | 70.00M |
| 327 | MCRB | Seres Therapeutics, Inc. | 150.72M | -6.93% | 90,149 | 351.00K |
| 328 | CHRS | Coherus Oncology, Inc. | 145.05M | -2.44% | 1,018,278 | 277.73M |
| 329 | INO | Inovio Pharmaceuticals, Inc. | 142.22M | 2.48% | 996,458 | 182.34K |
| 330 | CRDF | Cardiff Oncology, Inc. | 142.13M | -2.31% | 418,656 | 501.00K |
| 331 | ACOG | Alpha Cognition Inc. | 141.98M | 2.51% | 85,515 | 7.43M |
| 332 | CGEN | Compugen Ltd. | 141.24M | -6.21% | 155,513 | 6.90M |
| 333 | ELTX | Elicio Therapeutics, Inc. | 139.80M | -3.90% | 74,341 | - |
| 334 | GANX | Gain Therapeutics, Inc. | 139.53M | 10.00% | 2,518,839 | - |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 139.13M | -1.14% | 439,682 | 61.84M |
| 336 | MRSN | Mersana Therapeutics, Inc. | 138.84M | 1.11% | 48,214 | 33.18M |
| 337 | CNTB | Connect Biopharma Holdings Limited | 134.17M | -5.51% | 295,128 | 762.00K |
| 338 | UNCY | Unicycive Therapeutics, Inc. | 133.89M | -4.15% | 436,397 | - |
| 339 | AGEN | Agenus Inc. | 133.65M | -3.20% | 872,796 | 106.83M |
| 340 | ALEC | Alector, Inc. | 133.16M | 0.83% | 1,355,034 | 69.05M |
| 341 | NKTX | Nkarta, Inc. | 127.85M | -2.17% | 885,414 | - |
| 342 | SPRO | Spero Therapeutics, Inc. | 127.33M | -0.88% | 160,969 | 40.55M |
| 343 | TTRX | Turn Therapeutics Inc. | 126.91M | 1.41% | 59,283 | - |
| 344 | COYA | Coya Therapeutics, Inc. | 125.97M | 0.33% | 156,206 | 3.99M |
| 345 | FATE | Fate Therapeutics, Inc. | 124.58M | -1.82% | 738,696 | 7.14M |
| 346 | GLSI | Greenwich LifeSciences, Inc. | 123.86M | 1.59% | 71,655 | - |
| 347 | EXOZ | eXoZymes, Inc. | 123.50M | -1.84% | 628 | -700.00 |
| 348 | DTIL | Precision BioSciences, Inc. | 120.84M | - | 183,596 | 698.00K |
| 349 | ANVS | Annovis Bio, Inc. | 120.59M | -2.15% | 603,992 | - |
| 350 | PRLD | Prelude Therapeutics Incorporated | 120.30M | -5.19% | 292,779 | 10.50M |
| 351 | OVID | Ovid Therapeutics Inc. | 118.92M | 3.09% | 1,407,264 | 6.61M |
| 352 | ELDN | Eledon Pharmaceuticals, Inc. | 118.74M | -0.63% | 771,233 | - |
| 353 | WHWK | Whitehawk Therapeutics, Inc. | 117.35M | -2.73% | 92,737 | 14.38M |
| 354 | CLYM | Climb Bio, Inc. | 117.28M | -0.58% | 189,985 | - |
| 355 | SLGL | Sol-Gel Technologies Ltd. | 112.82M | -0.49% | 16,548 | 18.97M |
| 356 | IKT | Inhibikase Therapeutics, Inc. | 112.76M | -0.66% | 101,276 | 1.00 |
| 357 | ABOS | Acumen Pharmaceuticals, Inc. | 112.67M | -6.06% | 166,993 | - |
| 358 | CNTX | Context Therapeutics Inc. | 111.91M | 1.94% | 163,072 | - |
| 359 | KLRS | Kalaris Therapeutics, Inc. | 110.06M | -0.59% | 34,298 | - |
| 360 | ORMP | Oramed Pharmaceuticals Inc. | 107.07M | -1.10% | 55,552 | 2.00M |
| 361 | ONCY | Oncolytics Biotech Inc. | 105.31M | 1.16% | 562,123 | - |
| 362 | SEER | Seer, Inc. | 104.88M | -2.08% | 103,442 | 16.38M |
| 363 | ATRA | Atara Biotherapeutics, Inc. | 103.32M | 0.92% | 69,064 | 151.93M |
| 364 | ATOS | Atossa Therapeutics, Inc. | 103.25M | 5.24% | 844,277 | - |
| 365 | VANI | Vivani Medical, Inc. | 102.13M | -0.71% | 93,171 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 100.43M | -0.71% | 393,293 | 26.87M |
| 367 | HURA | TuHURA Biosciences, Inc. | 99.44M | -2.02% | 82,689 | - |
| 368 | ENTX | Entera Bio Ltd. | 98.59M | 1.90% | 115,667 | 124.00K |
| 369 | KPTI | Karyopharm Therapeutics Inc. | 98.04M | -2.71% | 64,488 | 142.53M |
| 370 | RPTX | Repare Therapeutics Inc. | 95.21M | -0.67% | 134,937 | 11.87M |
| 371 | ADVM | Adverum Biotechnologies, Inc. | 94.05M | 2.16% | 671,323 | 1.00M |
| 372 | ADAG | Adagene Inc. | 93.79M | 1.02% | 124,783 | 103.20K |
| 373 | ANEB | Anebulo Pharmaceuticals, Inc. | 92.85M | -4.64% | 7,739 | - |
| 374 | HYFT | MindWalk Holdings Corp. | 92.31M | -3.38% | 284,490 | 18.21M |
| 375 | OTLK | Outlook Therapeutics, Inc. | 91.06M | -0.49% | 2,046,483 | 1.51M |
| 376 | PSTV | Plus Therapeutics, Inc. | 89.33M | -0.76% | 8,644,751 | 5.26M |
| 377 | CBUS | Cibus, Inc. | 89.02M | 1.86% | 226,245 | 3.79M |
| 378 | FBIO | Fortress Biotech, Inc. | 87.84M | 2.91% | 285,127 | 62.30M |
| 379 | MGNX | MacroGenics, Inc. | 86.66M | -0.72% | 5,122,941 | 127.63M |
| 380 | VXRT | Vaxart, Inc. | 86.48M | -2.43% | - | 148.20M |
| 381 | ACET | Adicet Bio, Inc. | 86.38M | -3.75% | 2,148,366 | - |
| 382 | BMEA | Biomea Fusion, Inc. | 86.26M | 2.52% | 4,952,191 | - |
| 383 | SPRB | Spruce Biosciences, Inc. | 85.62M | -11.55% | 154,247 | 697.00K |
| 384 | COEP | Coeptis Therapeutics Holdings, Inc. | 83.84M | -4.38% | 80,038 | 501.00K |
| 385 | THAR | Tharimmune, Inc. | 83.76M | -3.24% | 167,409 | - |
| 386 | VRCA | Verrica Pharmaceuticals Inc. | 83.61M | 4.63% | 317,890 | 30.83M |
| 387 | CSBR | Champions Oncology, Inc. | 83.28M | -0.98% | 15,645 | 56.88M |
| 388 | ARTV | Artiva Biotherapeutics, Inc. | 82.47M | -10.99% | 142,863 | 251.00K |
| 389 | BYSI | BeyondSpring Inc. | 81.83M | 3.11% | 10,786 | 1.88M |
| 390 | PTHS | Pelthos Therapeutics Inc. | 81.35M | 0.80% | 34,327 | 7.41M |
| 391 | ATYR | aTyr Pharma, Inc. | 80.73M | -0.47% | 1,483,778 | 190.00K |
| 392 | CRVO | CervoMed Inc. | 80.41M | -4.08% | 56,827 | 6.16M |
| 393 | IMUX | Immunic, Inc. | 79.94M | -3.44% | 995,133 | - |
| 394 | TVGN | Tevogen Bio Holdings Inc. | 79.60M | -5.00% | 328,068 | - |
| 395 | ALXO | ALX Oncology Holdings Inc. | 76.99M | 3.65% | 266,319 | - |
| 396 | MNOV | MediciNova, Inc. | 76.51M | 0.65% | 99,512 | 257.92K |
| 397 | XBIT | XBiotech Inc. | 75.61M | -1.20% | 87,170 | - |
| 398 | ESLA | Estrella Immunopharma, Inc. | 75.15M | 3.11% | 80,856 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 74.79M | -1.66% | 337,348 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 74.35M | -7.63% | 4,098,556 | - |
| 401 | TIL | Instil Bio, Inc. | 74.06M | -4.21% | 50,581 | - |
| 402 | STRO | Sutro Biopharma, Inc. | 73.73M | -7.68% | 149,032 | 105.65M |
| 403 | OKYO | OKYO Pharma Limited | 71.84M | -4.98% | 70,831 | - |
| 404 | IFRX | InflaRx N.V. | 71.81M | -3.64% | 483,865 | 73.73K |
| 405 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 70.89M | 4.21% | 4,422,616 | - |
| 406 | IMA | ImageneBio, Inc. | 68.91M | -4.57% | 47,376 | 800.00K |
| 407 | OSTX | OS Therapies Incorporated | 67.61M | 5.49% | 529,814 | - |
| 408 | MGX | Metagenomi, Inc. | 66.83M | -0.56% | 406,624 | 30.91M |
| 409 | NRXP | NRx Pharmaceuticals, Inc. | 66.31M | -3.28% | 205,420 | 242.00K |
| 410 | KRRO | Korro Bio, Inc. | 66.11M | 3.08% | 602,083 | 7.37M |
| 411 | PYPD | PolyPid Ltd. | 66.04M | 0.76% | 112,996 | - |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 63.32M | -7.03% | 486,026 | - |
| 413 | CALC | CalciMedica, Inc. | 62.97M | -4.38% | 61,221 | - |
| 414 | ALGS | Aligos Therapeutics, Inc. | 61.47M | -0.99% | 33,843 | 2.65M |
| 415 | LITS | Lite Strategy, Inc. | 61.43M | -4.57% | 461,301 | - |
| 416 | TCRX | TScan Therapeutics, Inc. | 61.29M | -0.92% | 978,304 | 8.42M |
| 417 | NTRB | Nutriband Inc. | 57.92M | -4.74% | 18,612 | 2.58M |
| 418 | ATHE | Alterity Therapeutics Limited | 57.60M | -0.29% | 8,754 | 3.57M |
| 419 | ABVC | ABVC BioPharma, Inc. | 56.80M | -4.74% | 118,164 | 797.92K |
| 420 | CELU | Celularity Inc. | 56.09M | 0.35% | 50,278 | 40.58M |
| 421 | SNTI | Senti Biosciences, Inc. | 56.00M | -4.05% | 131,689 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 53.98M | -6.88% | 19,842 | - |
| 423 | EQ | Equillium, Inc. | 51.91M | -2.30% | 154,282 | 4.39M |
| 424 | CVM | CEL-SCI Corporation | 51.70M | 2.54% | 63,182 | - |
| 425 | ICCC | ImmuCell Corporation | 51.02M | 8.25% | 20,713 | 27.77M |
| 426 | INMB | INmune Bio, Inc. | 50.78M | 1.60% | 446,415 | 50.00K |
| 427 | IOBT | IO Biotech, Inc. | 50.13M | 2.74% | 1,037,215 | - |
| 428 | BCAB | BioAtla, Inc. | 48.43M | -2.85% | 588,376 | 11.00M |
| 429 | IBO | Impact BioMedical Inc. | 47.92M | -2.55% | 55,666 | 25.00K |
| 430 | JSPR | Jasper Therapeutics, Inc. | 47.85M | -8.06% | 1,132,581 | - |
| 431 | PDSB | PDS Biotechnology Corporation | 47.61M | -2.70% | 379,611 | - |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 47.10M | 0.74% | 141,455 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 46.20M | -4.48% | 305,529 | 1.14M |
| 434 | IPSC | Century Therapeutics, Inc. | 45.89M | -0.04% | 463,218 | 113.34M |
| 435 | KZR | Kezar Life Sciences, Inc. | 45.77M | - | 40,307 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 45.49M | -1.83% | 35,495 | - |
| 437 | BTAI | BioXcel Therapeutics, Inc. | 45.27M | -0.96% | 267,654 | 752.00K |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 44.61M | -1.38% | 85,603 | 90.00K |
| 439 | MAIA | MAIA Biotechnology, Inc. | 44.44M | - | 241,776 | - |
| 440 | GNTA | Genenta Science S.p.A. | 43.82M | 0.54% | 30,059 | - |
| 441 | EVAX | Evaxion A/S | 43.59M | -0.76% | 46,228 | 7.65M |
| 442 | CUE | Cue Biopharma, Inc. | 43.21M | -0.76% | 266,215 | 7.10M |
| 443 | LTRN | Lantern Pharma Inc. | 41.94M | -0.53% | 70,569 | - |
| 444 | NXTC | NextCure, Inc. | 41.79M | -3.10% | 24,986 | - |
| 445 | OKUR | OnKure Therapeutics, Inc. | 41.46M | 16.35% | 710,442 | - |
| 446 | QTTB | Q32 Bio Inc. | 40.85M | -8.29% | 580,915 | - |
| 447 | RADX | Radiopharm Theranostics Limited | 40.50M | 3.49% | 4,784 | 8.20M |
| 448 | VERU | Veru Inc. | 39.97M | 2.89% | 91,900 | 16.89M |
| 449 | JUNS | Jupiter Neurosciences, Inc. | 39.25M | -6.56% | 37,099 | - |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 39.21M | - | 85,739 | - |
| 451 | QNTM | Quantum BioPharma Ltd. | 38.88M | 0.40% | 70,461 | - |
| 452 | SKYE | Skye Bioscience, Inc. | 38.47M | -0.83% | 200,827 | - |
| 453 | XLO | Xilio Therapeutics, Inc. | 38.34M | -1.46% | 1,190,428 | 31.80M |
| 454 | ANL | Adlai Nortye Ltd. | 37.27M | -15.83% | 57,937 | 1.94M |
| 455 | GLTO | Galecto, Inc. | 36.45M | 19.97% | 130,902 | - |
| 456 | KLTO | Klotho Neurosciences, Inc. | 36.34M | 2.24% | 766,638 | - |
| 457 | GBIO | Generation Bio Co. | 35.91M | 2.68% | 21,431 | 15.27M |
| 458 | RNTX | Rein Therapeutics Inc. | 35.75M | -2.16% | 163,231 | - |
| 459 | MURA | Mural Oncology plc | 35.38M | -0.01% | - | - |
| 460 | APLM | Apollomics, Inc. | 34.92M | 10.31% | 26,559 | 198.00K |
| 461 | SER | Serina Therapeutics, Inc. | 34.66M | -6.34% | 24,698 | 116.00K |
| 462 | RNXT | RenovoRx, Inc. | 34.50M | -0.92% | 116,086 | 928.00K |
| 463 | DYAI | Dyadic International, Inc. | 34.38M | -4.99% | 87,625 | 3.34M |
| 464 | FGEN | FibroGen, Inc. | 34.06M | 2.06% | 20,747 | 8.30M |
| 465 | APLT | Applied Therapeutics, Inc. | 31.26M | -5.79% | 5,853,721 | 1.00M |
| 466 | XCUR | Exicure, Inc. | 31.23M | -27.30% | 170,612 | 500.00K |
| 467 | INTS | Intensity Therapeutics, Inc. | 30.63M | 10.80% | 8,400,859 | - |
| 468 | PLUR | Pluri Inc. | 30.35M | -2.45% | 24,875 | 1.33M |
| 469 | ANTX | AN2 Therapeutics, Inc. | 30.14M | 3.29% | 153,026 | - |
| 470 | BRNS | Barinthus Biotherapeutics plc | 29.45M | 0.04% | 10,265 | 14.97M |
| 471 | ENLV | Enlivex Therapeutics Ltd. | 29.39M | 4.31% | 1,052,945 | - |
| 472 | NRSN | NeuroSense Therapeutics Ltd. | 29.30M | -2.50% | 282,851 | - |
| 473 | LNAI | Lunai Bioworks Inc. | 29.29M | -3.85% | 212,005 | - |
| 474 | PASG | Passage Bio, Inc. | 29.28M | 0.29% | 91,615 | - |
| 475 | NRXS | NeurAxis, Inc. | 28.44M | -1.48% | 22,961 | 3.36M |
| 476 | RLYB | Rallybio Corporation | 27.96M | -0.72% | 59,056 | 674.00K |
| 477 | HYPD | Hyperion DeFi, Inc. | 27.86M | -2.02% | 107,137 | 345.32K |
| 478 | IGC | IGC Pharma, Inc. | 27.67M | -2.68% | 397,005 | 1.11M |
| 479 | KZIA | Kazia Therapeutics Limited | 27.61M | 12.48% | 224,412 | 1.20M |
| 480 | IBIO | iBio, Inc. | 26.98M | -6.25% | 628,405 | 500.00K |
| 481 | CING | Cingulate Inc. | 26.96M | 1.27% | 118,475 | - |
| 482 | NERV | Minerva Neurosciences, Inc. | 26.85M | 2.67% | 24,204 | - |
| 483 | PLRZ | Polyrizon Ltd. | 25.86M | -9.66% | 2,092,918 | - |
| 484 | CLGN | CollPlant Biotechnologies Ltd. | 25.68M | -4.29% | 16,213 | 2.48M |
| 485 | BOLD | Boundless Bio, Inc. | 25.52M | 3.64% | 267,849 | - |
| 486 | DARE | Daré Bioscience, Inc. | 25.43M | -0.56% | 37,814 | -57.13K |
| 487 | KTTA | Pasithea Therapeutics Corp. | 25.31M | -2.59% | 1,286,245 | - |
| 488 | ITRM | Iterum Therapeutics plc | 24.92M | 7.27% | 2,256,029 | 390.00K |
| 489 | LEXX | Lexaria Bioscience Corp. | 23.56M | -5.36% | 190,466 | 705.92K |
| 490 | BCTX | BriaCell Therapeutics Corp. | 23.16M | -6.94% | 50,571 | - |
| 491 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.10M | -4.71% | 63,153 | - |
| 492 | NEUP | Neuphoria Therapeutics Inc. | 22.96M | - | 58,898 | 15.65M |
| 493 | APVO | Aptevo Therapeutics Inc. | 22.75M | -2.88% | 490,998 | - |
| 494 | LIMN | Liminatus Pharma, Inc. | 22.71M | -11.96% | 408,674 | - |
| 495 | PTN | Palatin Technologies, Inc. | 22.39M | 4.59% | 69,417 | 8.85M |
| 496 | NNVC | NanoViricides, Inc. | 22.14M | 0.82% | 337,431 | - |
| 497 | MRKR | Marker Therapeutics, Inc. | 22.01M | -7.04% | 353,309 | 4.69M |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 21.80M | -5.60% | 262,873 | - |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 21.13M | -8.29% | 38,375 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 20.43M | -4.32% | 11,633 | 573.19K |
| 501 | CASI | CASI Pharmaceuticals, Inc. | 19.73M | -1.86% | 35,014 | 26.85M |
| 502 | OSRH | OSR Holdings, Inc. | 18.87M | 5.98% | 948,836 | -90.52K |
| 503 | HOTH | Hoth Therapeutics, Inc. | 18.62M | 0.84% | 116,169 | - |
| 504 | KAPA | Kairos Pharma, Ltd. | 18.53M | -2.12% | 161,988 | - |
| 505 | TRAW | Traws Pharma, Inc. | 18.30M | -2.97% | 92,663 | 2.85M |
| 506 | ALLR | Allarity Therapeutics, Inc. | 18.03M | -1.72% | 59,212 | - |
| 507 | MTVA | MetaVia Inc. | 18.01M | 11.77% | 1,469,789 | - |
| 508 | LPCN | Lipocine Inc. | 17.49M | 1.61% | 26,307 | 4.32M |
| 509 | CRIS | Curis, Inc. | 17.45M | - | 102,887 | 11.65M |
| 510 | LSTA | Lisata Therapeutics, Inc. | 17.38M | -2.96% | 25,859 | 1.07M |
| 511 | NCNA | NuCana plc | 17.36M | -5.87% | 54,806 | - |
| 512 | PMN | ProMIS Neurosciences, Inc. | 17.02M | 3.60% | 57,658 | - |
| 513 | NCEL | NewcelX Ltd. | 16.59M | 0.83% | 31,434 | - |
| 514 | SNGX | Soligenix, Inc. | 16.24M | -1.23% | 790,155 | 2.34K |
| 515 | FBLG | FibroBiologics, Inc. | 16.16M | 1.42% | 1,492,633 | - |
| 516 | CLRB | Cellectar Biosciences, Inc. | 15.99M | -0.79% | 7,486 | - |
| 517 | CANF | Can-Fite BioPharma Ltd. | 15.80M | -7.67% | 900,414 | 560.00K |
| 518 | ABP | Abpro Holdings, Inc. | 15.78M | -8.79% | 26,967 | 183.00K |
| 519 | PCSA | Processa Pharmaceuticals, Inc. | 15.75M | 2.51% | 474,137 | - |
| 520 | ATHA | Athira Pharma, Inc. | 15.58M | 0.13% | 10,398 | - |
| 521 | TPST | Tempest Therapeutics, Inc. | 15.37M | -8.77% | 158,647 | - |
| 522 | CMMB | Chemomab Therapeutics Ltd. | 15.26M | 0.40% | 52,320 | - |
| 523 | PULM | Pulmatrix, Inc. | 14.90M | -4.45% | 19,110 | 3.00K |
| 524 | MBRX | Moleculin Biotech, Inc. | 14.74M | -6.10% | 79,263 | - |
| 525 | BCDA | BioCardia, Inc. | 14.54M | -6.80% | 74,988 | 3.00K |
| 526 | PHIO | Phio Pharmaceuticals Corp. | 14.10M | -2.96% | 283,009 | - |
| 527 | COCP | Cocrystal Pharma, Inc. | 14.06M | -1.45% | 19,293 | - |
| 528 | DWTX | Dogwood Therapeutics, Inc. | 13.78M | -2.12% | 36,158 | - |
| 529 | BLRX | BioLineRx Ltd. | 13.69M | 3.78% | 6,398 | 12.74M |
| 530 | LGVN | Longeveron Inc. | 13.12M | -2.80% | 355,120 | 1.44M |
| 531 | ICU | SeaStar Medical Holding Corporation | 12.96M | 0.14% | 994,899 | 881.00K |
| 532 | EDSA | Edesa Biotech, Inc. | 12.39M | 4.14% | 41,610 | - |
| 533 | VYNE | VYNE Therapeutics Inc. | 12.32M | -1.12% | 378,479 | 524.00K |
| 534 | SNSE | Sensei Biotherapeutics, Inc. | 12.26M | -7.95% | 1,109,131 | - |
| 535 | AKTX | Akari Therapeutics, Plc | 12.12M | -0.29% | 135,292 | - |
| 536 | SYBX | Synlogic, Inc. | 12.05M | -10.43% | 66,133 | 8.00K |
| 537 | IMNN | Imunon, Inc. | 11.97M | -2.50% | 10,729 | - |
| 538 | BIVI | BioVie Inc. | 11.91M | -1.86% | 43,072 | - |
| 539 | IMRN | Immuron Limited | 11.42M | -3.21% | 279,398 | 4.78M |
| 540 | PPCB | Propanc Biopharma, Inc. | 11.22M | 1.73% | 66,131 | - |
| 541 | GOVX | GeoVax Labs, Inc. | 11.20M | -1.69% | 724,667 | 3.35M |
| 542 | APM | Aptorum Group Limited | 10.75M | -5.71% | 49,442 | - |
| 543 | CLDI | Calidi Biotherapeutics, Inc. | 10.68M | -5.19% | 74,463 | - |
| 544 | BOLT | Bolt Biotherapeutics, Inc. | 10.40M | 2.07% | 5,854 | 5.20M |
| 545 | ERNA | Ernexa Therapeutics Inc. | 10.36M | 0.76% | 33,742 | 1,000.00 |
| 546 | QNRX | Quoin Pharmaceuticals, Ltd. | 10.14M | -36.07% | 539,635 | - |
| 547 | BRTX | BioRestorative Therapies, Inc. | 9.85M | - | 18,580 | 383.40K |
| 548 | ASBP | Aspire Biopharma Holdings, Inc. | 9.83M | -0.54% | 11,236,498 | 1.94K |
| 549 | SLXN | Silexion Therapeutics Corp | 9.44M | -4.64% | 42,377 | - |
| 550 | EVGN | Evogene Ltd. | 9.24M | 0.91% | 17,686 | 8.02M |
| 551 | MBIO | Mustang Bio, Inc. | 9.12M | -5.30% | 27,843 | - |
| 552 | CELZ | Creative Medical Technology Holdings, Inc. | 8.65M | 5.41% | 112,428 | 6.00K |
| 553 | ALZN | Alzamend Neuro, Inc. | 8.55M | 4.65% | 63,409 | - |
| 554 | INAB | IN8bio, Inc. | 8.30M | -1.65% | 26,182 | - |
| 555 | PMCB | PharmaCyte Biotech, Inc. | 8.29M | 0.83% | 22,084,905 | - |
| 556 | XTLB | XTL Biopharmaceuticals Ltd. | 8.16M | -2.67% | 8,154 | 451.00K |
| 557 | BGMS | Bio Green Med Solution, Inc. | 8.13M | -8.79% | 44,273 | 81.00K |
| 558 | TCRT | Alaunos Therapeutics, Inc. | 8.06M | 0.56% | 61,876 | 6.00K |
| 559 | AEON | AEON Biopharma, Inc. | 7.95M | -10.23% | 233,797 | - |
| 560 | RNAZ | TransCode Therapeutics, Inc. | 7.90M | -0.30% | 8,199 | - |
| 561 | PHGE | BiomX Inc. | 7.89M | 8.39% | 175,201 | - |
| 562 | ADXN | Addex Therapeutics Ltd | 7.76M | -7.28% | 2,379 | 198.82K |
| 563 | GNPX | Genprex, Inc. | 7.63M | 0.30% | 300,800 | - |
| 564 | TOVX | Theriva Biologics, Inc. | 7.61M | -6.66% | 2,732,234 | - |
| 565 | LYRA | Lyra Therapeutics, Inc. | 7.58M | -5.11% | 20,945 | 600.00K |
| 566 | PPBT | Purple Biotech Ltd | 7.45M | -2.16% | 163,284 | - |
| 567 | KPRX | Kiora Pharmaceuticals, Inc. | 7.45M | -5.58% | 26,111 | 20.00K |
| 568 | ADIL | Adial Pharmaceuticals, Inc. | 7.40M | -5.40% | 238,037 | - |
| 569 | KALA | KALA BIO, Inc. | 7.39M | -6.64% | 11,339,113 | - |
| 570 | GRI | GRI Bio, Inc. | 6.73M | -3.74% | 215,601 | - |
| 571 | ACXP | Acurx Pharmaceuticals, Inc. | 6.69M | -7.76% | 49,823 | - |
| 572 | APRE | Aprea Therapeutics, Inc. | 6.69M | - | 26,573 | 488.24K |
| 573 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.67M | 20.07% | 36,679 | 15.78K |
| 574 | GTBP | GT Biopharma, Inc. | 6.48M | -3.24% | 1,098,587 | - |
| 575 | CYCN | Cyclerion Therapeutics, Inc. | 6.39M | -1.18% | 31,823 | 2.86M |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 6.14M | -0.88% | 237,813 | - |
| 577 | REVB | Revelation Biosciences, Inc. | 6.13M | 3.50% | 84,452 | - |
| 578 | VIVS | VivoSim Labs, Inc. | 6.05M | 1.31% | 19,343 | 140.00K |
| 579 | SILO | Silo Pharma, Inc. | 5.84M | -2.81% | 60,992 | 72.10K |
| 580 | ENSC | Ensysce Biosciences, Inc. | 5.81M | 0.61% | 37,850 | 4.49M |
| 581 | XBIO | Xenetic Biosciences, Inc. | 5.80M | -0.39% | 21,958 | 2.86M |
| 582 | HCWB | HCW Biologics Inc. | 5.35M | -2.94% | 15,715 | 422.03K |
| 583 | MTNB | Matinas BioPharma Holdings, Inc. | 5.06M | 5.19% | 20,633 | - |
| 584 | SLRX | Salarius Pharmaceuticals, Inc. | 4.84M | -5.23% | 586,140 | - |
| 585 | JAGX | Jaguar Health, Inc. | 4.42M | -1.82% | 132,063 | 11.79M |
| 586 | INDP | Indaptus Therapeutics, Inc. | 4.38M | 16.82% | 86,750 | - |
| 587 | XRTX | XORTX Therapeutics Inc. | 4.21M | -0.03% | 58,238 | - |
| 588 | VRAX | Virax Biolabs Group Limited | 4.12M | -2.24% | 1,542,052 | 2.99K |
| 589 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.12M | -0.68% | 159,645 | 1.36M |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 4.09M | 1.38% | 8,606 | - |
| 591 | ENVB | Enveric Biosciences, Inc. | 4.05M | 11.13% | 114,346 | - |
| 592 | ONCO | Onconetix, Inc. | 4.02M | -12.71% | 25,007 | 1.22M |
| 593 | SCNI | Scinai Immunotherapeutics Ltd. | 3.83M | 12.15% | 150,572 | 1.15M |
| 594 | ARTL | Artelo Biosciences, Inc. | 3.71M | -10.68% | 229,259 | - |
| 595 | AZTR | Azitra, Inc. | 3.70M | -0.93% | 128,446 | 7.50K |
| 596 | ELAB | PMGC Holdings Inc. | 3.69M | -0.40% | 13,076 | 285.95K |
| 597 | OGEN | Oragenics, Inc. | 3.68M | 3.75% | 239,228 | - |
| 598 | PBM | Psyence Biomedical Ltd. | 3.29M | -2.76% | 61,934 | - |
| 599 | PTIX | Protagenic Therapeutics, Inc. | 3.23M | -0.60% | 83,542 | - |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 3.12M | -0.98% | 1,114,910 | 104.90K |
| 601 | CDT | CDT Equity Inc. | 2.92M | -1.65% | 170,934 | - |
| 602 | DRMA | Dermata Therapeutics, Inc. | 2.87M | 11.11% | 2,305,580 | - |
| 603 | SPRC | SciSparc Ltd. | 2.82M | -1.69% | 14,276,232 | 1.31M |
| 604 | CMND | Clearmind Medicine Inc. | 2.67M | -2.34% | 7,571,039 | - |
| 605 | MLEC | Moolec Science SA | 1.88M | -5.02% | 111,513 | 7.83M |
| 606 | ADTX | Aditxt, Inc. | 1.72M | 5.84% | 3,860,500 | 5.95K |